Cryoablation: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Cryoablation

• A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
  NCT06246968 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
  NCT05972343 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CRYoablation for Small Tumors As Local Treatment - SIX Trial
  NCT06839001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine
  NCT07380789 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
  NCT06265350 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma
  NCT07070700 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
  NCT07306286 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
  NCT05218044 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
  NCT04339218 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Cryoablation+Ipilimumab+Nivolumab in Melanoma
  NCT05779423 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
  NCT07567027 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 95 Years · Sex: Male · 1 location
• Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine
  NCT07416448 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Percutaneous Cryoablation of Low-risk Early Breast Cancer
  NCT06300125 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
  NCT07629206 · Phase: Not applicable (e.g. observational or device study) · Ages: 70 Years and older · Sex: All (male and female) · 2 locations
• Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium
  NCT06253000 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules
  NCT07232433 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC
  NCT06127303 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations

Common questions

How many recruiting trials involve Cryoablation?

17 recruiting trials across 15 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.